Business
Made Scientific and Regenicin Announce Manufacturing Relationship to Advance NovaDerm Toward FDA Product Approval
Made Scientific, Inc., a U.S.-based cell therapy contract development and manufacturing organization (CDMO), and Regenicin, Inc., a biotechnology company specializing in the development and commercialization of regenerative cell therapies to restore the health of damaged tissues and organs, today announced a manufacturing relationship to advance NovaDerm, an autologous cultured skin substitute for severe burns and chronic wounds, toward a U.S. FDA Orphan product approval.
About this update from Regenicin Inc
[{"type":"text","content":"Made Scientific to support clinical manufacturing of NovaDerm, an autologous cultured skin substitute for the treatment of severe burns and chronic wounds","length":154,"tagName":"p"},{"type":"text","content":"PRINCETON, N.J., April 22, 2026 /PRNewswire/ -- Made Scientific, Inc., a U.S.-based cell therapy contract development and manufacturing organization (CDMO), and Regenicin, Inc., a biotechnology company specializing in the development and commercialization of regenerative cell therapies to restore the health of damaged tissues and organs, today announced a manufacturing relationship to advance NovaDerm, an autologous cultured skin substitute for severe burns and chronic wounds, toward a U.S. FDA Orphan product approval.","length":524,"tagName":"p"},{"type":"image","alt":"Made Scientific, Inc. (PRNewsfoto/Made Scientific, Inc)","displaySize":"","headline":null,"caption":"Made Scientific, Inc. (PRNewsfoto/Made Scientific, Inc)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":145,"url":"https://media.zenfs.com/en/prnewswire.com/5685156474572b656ab4123bb054cc7a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/mF8cGHw2iZTPmkoW6tltNg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTI1Ng--/https://media.zenfs.com/en/prnewswire.com/5685156474572b656ab4123bb054cc7a","width":400,"height":145}},"href":"https://mma.prnewswire.com/media/2642492/Made_Scientific_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Under the agreement, Made Scientific will serve as the manufacturing partner for NovaDerm, providing end-to-end services at its Princeton, New Jersey GMP facility. The program establishes a clear pathway from technology transfer through GMP clinical production and regulatory support of Regenicin's Investigational New Drug (IND) submission and upcoming clinical trial.","length":373,"tagName":"p"},{"type":"text","content":""We are proud to work with Regenicin to advance NovaDerm into the clinic," said Syed T. Husain, Chairman and CEO of Made Scientific. "This collaboration reflects the strength of our manufacturing platform and our ability to execute complex autologous programs with the precision and regulatory rigor required for clinical success."","length":351,"tagName":"p"},{"type":"text","content":""Manufacturing a patient-specific treatment like No...